Skip to ContentSkip to Navigation
How to find us A.C.M. van den Bergh


Real-world outcomes of radium-223 dichloride for metastatic castration resistant prostate cancer

Spleen Dose Influences Overall Survival In The Neo-Adjuvant Treatment Of Esophageal Cancer

Feasibility planning study for hypofractionated salvage prostate bed radiotherapy

Feasibility study of extreme hypofractionated proton treatment planning for prostate cancer

Postoperative use of somatostatin analogs and mortality in patients with acromegaly

Re: Risk of solid cancer after treatment of testicular germ cell cancer in the platinum era

Second-Line Cabazitaxel Treatment in Castration-Resistant Prostate Cancer Clinical Trials Compared to Standard of Care in CAPRI: Observational Study in the Netherlands

Development of a prediction model for late urinary incontinence, hematuria, pain and voiding frequency among irradiated prostate cancer patients

Impact of cardiac dose on survival and toxicity after neo-adjuvant treatment for esophageal cancer.

Long term toxicity after radiotherapy for prostate cancer: NTCP models for rectal toxicity.

Read more